Tofacitinib Shows Promise for Treating Severe Alopecia Areata
The Janus kinase (JAK) inhibitor tofacitinib shows promise for treating severe alopecia areata and its variants in adults and adolescents, according to two retrospective studies. Reuters Health Information
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου